News
CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...
Women who replaced their lunchtime diet beverage with water had greater weight loss and achieved diabetes remission compared ...
Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...
Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, according to a speaker at the American Diabetes Association Scientific ...
This challenge Kickstarts additional investments through the new ADA Innovation Fund CHICAGO, June 21, 2025 /PRNewswire/ -- As the American Diabetes ...
Data presented simultaneously at the American Diabetes Association's® 85th Scientific Sessions, showed mean weight reduction ...
Diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments such as ...
Novo Nordisk A/S’s next-generation obesity shot CagriSema helped patients lose weight in large studies despite only about ...
Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug’s blockbuster potential in the company’s compe ...
Danish group lost €90bn in market capitalisation in December after preliminary results showed it missed its target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results